文献速递脊柱关节炎

强直性脊柱炎风险变异通过PSMB1抑制破骨细胞分化

An ankylosing spondylitis risk variant alters osteoclast differentiation.
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

该研究纳入1037例强直性脊柱炎(AS)患者和1014例无风湿及关节炎疾病对照,发现蛋白酶体基因PSMB1非同义SNP rs12717与AS显著相关,CC基因型者发病风险高于GG/GC基因型者(OR=1.89,P=0.0047)。功能实验显示疾病相关变异PSMB1-Pro11较PSMB1-Ala11通过降解IKK-β显著抑制RANKL诱导的NF-κB通路及破骨细胞分化,PSMB1 31C/31C基因型者原代单核破骨前体细胞的RANKL诱导破骨分化显著低于31G/31G基因型者。

要点

  • PSMB1 rs12717 CC基因型者AS发病风险高于GG/GC基因型者(OR=1.89,P=0.0047)。
  • PSMB1-Pro11较PSMB1-Ala11通过降解IKK-β显著抑制RANKL诱导的NF-κB通路。
  • PSMB1 31C/31C基因型者破骨前体细胞RANKL诱导破骨分化显著低于31G/31G基因型者。

核心结论

  • 结果揭示AS骨形成与骨吸收失衡的新认识,新骨形成表型可归因于功能更强的PSMB1基因对破骨细胞分化的抑制。

研究设计与样本

  • 病例对照分析鉴定AS易感基因,采用双荧光素酶报告基因实验、免疫印迹分析和破骨细胞生成实验检测阳性变异的功能。
  • 研究纳入1037例AS患者和1014例无风湿及关节炎疾病对照,AS患者由至少两名经验丰富的风湿科医生按修订纽约标准诊断并由另一名风湿科医生复核。

主要发现

  • AS患者主要发病年龄为16至35岁,HLA-B27阳性者占患者的90.0%。
  • 蛋白酶体基因PSMB1非同义SNP rs12717与AS显著相关,CC基因型者较GG/GC基因型者发病风险更高(OR=1.89,P=0.0047)。
  • PSMB1调控RANK/RANKL信号通路,疾病相关变异PSMB1-Pro11较PSMB1-Ala11通过降解IKK-β显著抑制RANKL诱导的NF-κB通路。
  • PSMB1 31C/31C基因型者原代单核破骨前体细胞的RANKL诱导破骨分化显著低于31G/31G基因型者。

关键数值与推荐

  • AS诊断依据修订纽约标准,由至少两名经验丰富的风湿科医生诊断并由另一名风湿科医生复核。
  • PSMB1 rs12717 CC基因型者较GG/GC基因型者AS发病风险OR=1.89(P=0.0047)。
  • HLA-B27阳性者占AS患者的90.0%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore whether the variants in non MHC proteasome gene are associated with AS and explain the role of the variant in the disease. MATERIAL AND METHODS: Case-control analysis to identify AS predisposition genes; dual-luciferase reporter assay, immunoblot analysis and osteoclastogenesis assays to detect the function of the positive variant. Affected individuals were diagnosed according to the modified New York Criteria by at least two experienced rheumatologists, and rechecked by another rheumatologist. RESULTS: The study included 1037 AS patients and 1014 no rheumatic and arthritis disease controls. The main age of AS onset is between 16 and 35 years old. HLA-B27-positive subjects comprised 90.0% of patients. A nonsynonymous SNP rs12717 in proteasome gene PSMB1 significantly associated with AS. Individuals with CC genotype had a higher onset risk compared with those with GG/GC genotypes (OR = 1.89, P = 0.0047). We also discovered that PSMB1 regulates the receptor activator of nuclear factor-κB (RANK)/RANK ligand (RANKL) signalling pathway and the disease-associated variant PSMB1-Pro11 significantly inhibits RANKL-induced NF-κB pathway in osteoclast differentiation via the degradation of IKK-β compared with PSMB1-Ala11. RANKL induced osteoclast differentiation was significantly lower in primary monocyte osteoclast precursor from individuals with genotype PSMB131C/31C compared with individuals with genotype PSMB131G/31G. CONCLUSIONS: These results reveal a novel understanding of the bone formation and reabsorbing imbalance in AS. The new bone formation phenotype can be attributed to the inhibition of osteoclast differentiation by a more functional PSMB1 gene.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Wu F, Han X, Liu J, et al. An ankylosing spondylitis risk variant alters osteoclast differentiation. Rheumatology (Oxford). 2023. PMID: 36124946. doi:10.1093/rheumatology/keac542

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。